Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Medical - Devices

Healthcare
$103.32 +1.00%

+$0.87 today

Market cap
$19.55B
Beta
0.47
P/E (TTM)
22.5
EPS (TTM)
$3.90
Dividend yield
1.09%
52W Low $79.12High $108.29

Volume 2.34M

Average 2.28M

ZBH Free Cash Flow

Operating cash flow minus capital expenditures: cash available for debt repayment, dividends, and buybacks.

Zimmer Biomet Holdings, Inc.NYSE: ZBH

Free Cash Flow · Q2 FY2026 · quarter ended Jun 2026

Free cash flow grows, but more slowly than its trailing trend

Q2 FY2026 free cash flow of $331.4M rose 11.2% year over year, behind the +28.5% change in trailing-twelve-month free cash flow. Sequentially, it rose 16.6% from the prior quarter. Over 3 fiscal years it compounded at +11.3% a year.

Context

  • Free cash flow amounted to 17.9% of revenue in FY2025, up 3.0 pp from a year earlier.
  • Free cash flow increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from +11.2% toward the trailing-twelve-month pace of +28.5%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterJun 2026
$331.4M+16.6% QoQ
Last fiscal yearDec 2025
$1.47B+28.9% YoY
LTMJun 2026
$1.83B+28.5% YoY
Free Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+11.2%——
1 year+28.9%——
3-year CAGR+11.3%——
5-year CAGR——
10-year CAGR——

Free Cash Flow history

USD · from the cash flow

Latest · FY2025
1.47B USD
Year-over-year change
+28.9%
4-year CAGR
+2.2%

Free Cash Flow vs competitors

How ZBH compares with its peers on the latest reported figures

  • Peers report in different currencies, so free cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +28.5% is the 4th highest of 10, against a peer median of +15.6%.
  • Free cash flow amounts to 21.5% of revenue for ZBH, versus a peer median of 16.3%.
ZBH Competitors
Free Cash Flow for ZBH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MDTMedtronic plcLTM Jul 2026$6.13B USD+15.6%+5.8%16.3%
SYKStryker CorporationLTM Jun 2026$4.7B USD+16.8%+28.1%18.2%
BSXBoston Scientific CorporationLTM Jun 2026$3.63B USD+9.5%+58.8%17.3%
PHGKoninklijke Philips N.V.LTM Jun 2026€1.9B EUR+334.4%—10.8%
ZBHZimmer Biomet Holdings, Inc.LTM Jun 2026$1.83B USD+28.5%+11.3%21.5%
EWEdwards Lifesciences CorporationLTM Jun 2026$1.43B USD+135.8%+11.9%22.0%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026$895M USD-42.8%-5.8%4.4%
SNNSmith & Nephew plcFY2025$852M USD+40.6%+97.9%13.8%
ALGNAlign Technology, Inc.LTM Jun 2026$755.7M USD+11.4%+21.0%18.3%
OFIXOrthofix Medical Inc.LTM Mar 2026$3.63M USD-24.4%-66.7%0.4%
Peer median (excluding ZBH) —+15.6%+16.5%16.3%

Competitors are the stored peer set for ZBH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income445.5M291.2M1.03B905.2M705.1M
Depreciation & Amortization937.7M926.4M951.7M996.3M1.09B
Deferred Income Tax(102.1M)(64.4M)(96.3M)(47.7M)(87.2M)
Stock-Based Compensation76M105M99.8M101M90.2M
Change in Working Capital(134.2M)(311.4M)(396.2M)(455.4M)(104.9M)
Accounts Receivables(40.8M)(184.7M)(51.9M)(89.7M)(127.3M)
Inventory(8.4M)(75.6M)(240.4M)49.9M98.2M
Accounts Payables86.5M103M(55.3M)(322M)101.8M
Other Working Capital(171.5M)(154.1M)(48.6M)(93.6M)(177.6M)
Other Non-Cash Items276.3M337.9M(2.5M)0100K
Operating Cash Flow1.5B1.28B1.58B1.5B1.7B
Capital Expenditures(152M)(217.6M)(394.5M)(356.8M)(224.5M)
Acquisitions (Net)0(99.8M)(134.9M)(276.3M)(1.39B)
Purchases of Investments(273.6M)(258.3M)(311.7M)(240.3M)(300.5M)
Sales of Investments1.9M89.4M33.4M22.1M0
Other Investing Activities(88.3M)(72.6M)(74.6M)(189.8M)(57.5M)
Investing Cash Flow(503.6M)(529.2M)(778.9M)(888.1M)(1.98B)
Debt Repayment(1.06B)(1.06B)54.6M536.3M1.03B
Common Stock Issued122.5M00039.7M
Common Stock Repurchased0(126.4M)(692.2M)(868M)(487M)
Dividends Paid(200.1M)(201.2M)(200.9M)(196M)(190.3M)
Other Financing Activities(173.4M)544.5M75M43.2M(65.5M)
Financing Cash Flow(1.31B)(843.8M)(763.5M)(484.5M)326M
Effect of Forex Changes(13.2M)(14.5M)900K(17.1M)19M
Net Change in Cash(323.6M)(102.8M)40.1M109.7M66.4M
Free Cash Flow1.35B1.07B1.19B1.14B1.47B

Zimmer Biomet Holdings, Inc.

NYSE:ZBH

Intrinsic Alpha fair value

Locked

Current Price

$103.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.